Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Urinary Bladder Neoplasms 3Renal Insufficiency, Chronic 2Prostatic Neoplasms 2Uterine Prolapse 1Urologic Neoplasms 1Urinary Tract Infections 1Staphylococcal Infections 1Spasm 1Sleep Initiation and Maintenance Disorders 1Skin Sympathetic Nerve Activity During General Anesthesia in Patients Undergoing Breast Cancer Surgery 1Sepsis 1Seizures 1Schizophrenia, Treatment-Resistant 1Schizophrenia 1Retinitis 1Pulmonary Arterial Hypertension 1Pneumonia 1Pain 1Neutropenia 1Neuromuscular Blockade 1Muscle Hypotonia 1Migraine Disorders 1Menorrhagia 1Meningitis, Bacterial 1Meningitis 1Melanoma 1Lung Neoplasms 1Leiomyoma 1Intraabdominal Infections 1Intestinal Obstruction 1

Interventions

Anesthesia, General 2Rocuronium 1Magnesium Sulfate 1Anesthesia, Epidural 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anesthesia × Rocuronium × Clear all
NCT04510337 2021-03-05

Does Adding Magnesium Sulphate to Low Dose Rocuronium Affects Depth of Blockade

National Cancer Institute, Egypt

Phase NA Completed
60 enrolled

Anesthesia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡